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Background: Visceral fat accumulation is associated with metabolic disease. It is therefore relevant to study factors
that regulate adipose tissue distribution. Recent data shows that overeating saturated fatty acids promotes greater
visceral fat storage than overeating unsaturated fatty acids. Visceral adiposity is observed in states of hypercortisolism,
and the enzyme 11-β-hydroxysteroid-dehydrogenase type 1 (11β-hsd1) is a major regulator of cortisol activity by
converting inactive cortisone to cortisol in adipose tissue. We hypothesized that tissue fatty acid composition regulates
body fat distribution through local effects on the expression of 11β-hsd1 and its corresponding gene (HSD11B1)
resulting in altered cortisol activity.
Findings: Visceral- and subcutaneous adipose tissue biopsies were collected during Roux-en-Y gastric bypass surgery
from 45 obese women (BMI; 41 ± 4 kg/m2). The fatty acid composition of each biopsy was measured and correlated to
the mRNA levels of HSD11B1. 11β-hsd1 protein levels were determined in a subgroup (n = 12) by western blot analysis.
Our main finding was that tissue saturated fatty acids (e.g. palmitate) were associated with increased 11β-hsd1 gene- and
protein-expression in visceral but not subcutaneous adipose tissue.
Conclusions: The present study proposes a link between HSD11B1 and saturated fatty acids in visceral, but not
subcutaneous adipose tissue. Nutritional regulation of visceral fat mass through HSD11B1 is of interest for the modulation
of metabolic risk and warrants further investigation.
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Increased visceral adipose tissue (VAT) mass is strongly
associated with metabolic disorders whereas subcutaneous
adipose tissue (SAT) expansion is regarded as less detri-
mental [1]. Body fat distribution is influenced by age, eth-
nicity and gender [2,3], and is under hormonal influence
by e.g. cortisol and other steroid hormones [4]. However,
body fat distribution may also be regulated by modifiable
lifestyle factors such as diet. Recently, dietary fatty acid
(FA) quality was shown to influence body composition* Correspondence: ulf.riserus@pubcare.uu.se
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unless otherwise stated.and body fat distribution during hyper- and iso-caloric
conditions in humans [5,6].
Cortisol has a major impact on body fat accumulation.
VAT has a higher concentration of glucocorticoid receptors
than SAT [4], and lipoprotein lipase activity is increased by
cortisol with depot specific differences [7]. The local con-
centrations of cortisol are regulated by the enzyme 11-β-
hydroxysteroid-dehydrogenase type 1 (11β-hsd1) encoded
by HSD11B1, which in humans converts inactive cortisone
into active cortisol. Recent data obtained in murine models,
suggest that increased tissue production of cortisol by 11β-
hsd1 is critical for developing the characteristic phenotype
linked to conditions of hypercortisolism, e.g. VAT accumu-
lation and insulin resistance [8]. Mice lacking HSD11B1This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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are observed in mice over-expressing HSD11B1 [10]. In
humans, inhibition of 11β-hsd1 activity resulted in reduced
VATand liver fat content compared to placebo [11].
Interestingly, via as of yet unclear mechanisms, FAs that
influence visceral fat accumulation in humans [6] have also
been shown to regulate the expression of HSD11B1 in rat
VAT [12]. Thus, polyunsaturated FAs (PUFAs) inhibited,
whereas saturated FAs (SFAs) increased HSD11B1 expres-
sion in adipose tissue, which could link the differential ef-
fects of these FAs on VATaccumulation in humans.
As cortisol is a known regulator of body fat distribu-
tion and body composition, we hypothesized that FA
composition in VAT influences HSD11B1 gene and pro-
tein expression which could in turn influence VAT accu-
mulation. Accordingly, we investigated the associations
between saturated and unsaturated FA proportions and
HSD11B1/11β-hsd1 expression in VAT and SAT col-
lected from obese subjects.
Material and methods
Subjects
Forty-five obese women without diabetes that underwent a
laparoscopic Roux-en-Y gastric bypass surgery at Uppsala
University Hospital were recruited. Diabetes was defined as
previous diagnosis or glucose lowering treatment, or a fast-
ing plasma glucose ≥7.0 mmol/l or ≥11.1 mmol/l 2 h after
an oral glucose tolerance test. According to local guidelines,
patients were assigned a low calorie diet (LCD, maximum
1200 kcal/day), during one month prior to surgery. Written
informed consent was obtained from all subjects. The study
was approved by the regional Ethical board in Uppsala.
Adipose tissue biopsies
During surgery, we collected biopsies from two different
adipose tissue depots; SAT was collected from the upper
left side of the abdomen, whereas VAT was collected
from the omentum. Biopsies were washed in isotonic
saline solution, placed in Eppendorf tubes and snap frozen
using dry ice and ethanol.
Fatty acid composition measurement with gas
chromatography
FA composition (individual saturated, monounsaturated
and polyunsaturated FAs) was measured in VAT and SAT
biopsies using gas–liquid chromatography [5,13]. FAs were
expressed as percentages of the total FAs analysed.
RNA extraction, cDNA synthesis and qRT-PCR
Total RNA was extracted from all subjects using miRNeasy
Mini kit (Qiagen, Hilden Germany). RNA concentration
and purity was measured spectrofotometrically using a
Nanodrop ND-2000 Spectrophotometer (Thermo Fischer
Scientific, MA USA). High RNA quality was confirmed in16 randomly chosen samples using Agilent R6K ScreenTape
System (Agilent Technologies, Waldbronn Germany).
cDNA was synthesized using iScript™ cDNA Synthesis Kit
(Bio-Rad Laboratories, CA USA). The reverse transcription
incubation was performed in a PTC-100R Thermal Cycler
(Bio-Rad Laboratories). Relative gene-expression levels
were calculated using a standard curve. The qRT-PCR was
performed with iCycler IQ™ (Bio-Rad Laboratories, CA
USA). TaqMan® 2x universal PCR master mix (Applied
Biosystems, CA USA) and predesigned TaqMan® assay
(Applied Biosystem, CA USA) targeting HSD11B1 and the
housekeeping genes LRP10 and 18S were used according
to the manufacturer’s instructions.
Protein extraction and Western blot
The difference in HSD11B1 expression between SAT and
VAT were calculated for each individual and a subgroup in-
cluding the 12 subjects with the largest difference (SAT>
VAT) were selected for protein measurements. Adipose tis-
sues (99–101 mg) were homogenized with IKA® T10 basic
ULTRA-TURRAX ( IKA®-Werke GmbH & Co. KG, Staufen
Germany), protein concentration determined and western
blot performed as previously described [14]. Primary poly-
clonal goat IgG α-11β-hsd1- (R&D systems®, MN USA) and
secondary igG α-goat (Sigma Aldrich) antibodies were used.
Statistical analysis
All statistical analysis was performed using IBM SPSS
Statistics 22.0. Significant differences between two groups
were tested with students´ t-test. Correlations were
performed using Spearman’s correlation analysis.
Findings
Patients (n = 45) had a mean age of 40 ± 10 years and a
mean BMI of 41 ± 4 kg/m2. The subgroup for protein
analyses consisted of 12 patients with a mean age of
34 ± 8 years and a mean BMI of 42 ± 3 kg/m2.
HSD11B1 expression in SAT and VAT
While gene expression data indicated higher HSD11B1
mRNA expression in SAT than in VAT, reciprocal findings
were obtained at the protein level (Figure 1A). A statistically
significant correlation was found between the gene- and
protein expression only in VAT of the analysed sub-group
(n = 12) (Figure 1B).
Associations between tissue fatty acids and HSD11B1
The association between FA composition and gene ex-
pression was tested in SAT and VAT. The saturated FAs
14:0, 16:0 and18:0 correlated significantly with HSD11B1
expression in VAT. Additionally, total VAT SFA were
positively correlated whereas total VAT monounsaturated




Figure 1 HSD11B1 gene and 11β-hsd1 protein expression in adipose tissue depots. A. The gene expression of HSD11B1 differed significantly
between SAT and VAT with the higher gene expression in SAT whereas the protein expression was higher in VAT. Data are presented as means ±
SD (*, differ from VAT, P < 0.001). B. Correlations between HSD11B1 mRNA and 11β-hsd1 protein expression. Correlations between HSD11B1 mRNA
expression and 11β-hsd1 protein expression are illustrated in scatterplots. A statistically significant correlation is found only in the VAT (rho = 0.78
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Figure 2 Associations between HSD11B1 expression and individual fatty acids in VAT. Correlations between HSD11B1 expression and FA-composition
in the VAT are illustrated in scatterplots. Total SFA (rho = 0.39 and P = 0.006) and MUFA (rho = −0.38 and P = 0.007) together with the individual SFAs
14:0 (rho = 0.34 and P = 0.025) 16:0 (rho = 0.31 and P = 0.039) and 18:0 (rho = 0.30 and P = 0.049) correlated with HSD11B1 expression.
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Herein we investigated the associations between adipose
tissue FA composition and HSD11B1 expression in
humans. Our new findings suggest a potential distinct role
of saturated and unsaturated FAs in regulating HSD11B1
in human VAT. We found an association between total as
well as with several long-chain SFAs (e.g. palmitate) and
HSD11B1 expression in VAT, whereas the opposite associ-
ation was observed for total MUFAs. The association
between FAs and HSD11B1 expression were not present
in SAT. The reason for this is unknown but could be ex-
plained by the results from the western blot suggesting
that the gene and corresponding protein levels in SAT are
poorly correlated. These discrepancies may be due to
variation in post-transcriptional/-translational regulation
of the enzyme between the depots. However, it should also
be considered that the subgroup that was selected for pro-
tein measurement may not be representative of the study
population. The relationship between SFAs and HSD11B1
expression is in agreement with previous findings in rats
[12] and indicates a possible mechanism influencing fat
distribution. Prior studies in humans have shown that
dietary fat quality influences body composition and body
fat distribution with unfavourable effects from a diet rich
in SFAs (palmitate) when compared to a PUFA diet
[5,6,15]. The lack of inverse association between PUFAs
and HSD11B1 in VAT may be partly explained by a poten-
tially higher beta-oxidation of PUFAs compared with SFA
and MUFA resulting in lower PUFA storage in AT [16].
This possibility should be considered since the fat biopsies
were collected after a low-caloric diet promoting fat oxi-
dation and inhibiting fat storage. However, protective ef-
fects from MUFAs and PUFAs might be due to a decrease
in SFA content since no inverse correlations were detected
between HSD11B1 expression and PUFA content. Addi-
tionally, the effect of MUFA on HSD11B1 expression
could be due to the inverse correlation between SFA and





Figure 3 This schematic picture presents a hypothetical link between SFAs
and alter transcription of HSD11B1. The increased HSD11B1 expression in VA
which results in an elevated conversion of cortisone to cortisol. Cortisol bin
which results in VAT adipogenesis and increased hepatic lipid accumulatio
mechanism is simplified and a model extracted from the observed associatno known comparison between SFA and MUFA enriched
diets have been done with regard to HSD11B1 expression
or body fat distribution. The addition of PUFAs to the
diet, without substituting other FAs, may not influence
VAT mass as indicated by a post-hoc analyses [17]. Note-
worthy is that the energy balance of the diet may also in-
fluence since previous dietary FA interventions have been
performed under hypo-, iso- and hyper-caloric conditions
[5,6,17]. A direct effect of fatty acid species on HSD11B1
expression could be tested by stimulating in vitro differen-
tiated visceral and subcutaneous adipocytes with different
fatty acids. Such experiments could unfortunately not be
performed due to difficulties obtaining sufficient amount
of visceral adipose tissue from patients for cell culturing.
The molecular mechanisms explaining the associations
between FA type, body composition and gene expression
cannot be established from this study, however, our data to-
gether with others [6,10,12] can be extended to a theoretical
model of the underlying mechanism. A schematic and sim-
plified overview of the mechanisms is illustrated in Figure 3.
Noteworthy is that the response to cortisol stimulation var-
ies between AT depots, probably due to variations in the
transcription co-factor GC-dependent gene LIM domain
only 3 (LMO3) [18]. The signalling pathway explaining the
increased HSD11B1 expression upon SFA stimulation has
not been established. However, a possible signalling path-
way is through toll-like receptor 4. This receptor also binds
TNFα, a stimulator of HSD11B1 expression [19].
Strengths of the study include the relatively large sample
size, assessment of fatty acid composition together with
mRNA of HSD11B1 and protein analyses of its coding en-
zyme in two key abdominal adipose tissue depots. The con-
sistent association between several major SFAs (14:0, 16:0
and 18:0) and HSD11B1 expression however strengthens
the results and supports a potential SFA specific effect.
There are some limitations of the study. The study
population may not be representative for men and for







and HSD11B1 expression. SFAs may function as signalling molecules
T is associated with an increased protein expression of the enzyme
ds to the glucocorticoid receptor (GR) which regulates transcription
n due to induced AT lipolysis. It should be noted that the suggested
ions and ought to be confirmed before considered valid.
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LCD which could influence with gene expression. The FA
composition is not believed to be significantly influenced
since the triglyceride turnover is much longer than
1 month [20], although fatty acids may be differently oxi-
dized and thereby influencing adipose tissue FA compos-
ition [16]. Although both gene- and protein- expression
was measured, we lack information on enzyme activity
and cortisol levels. Due to the diurnal and inter-individual
variation, a 24 h urine collection is needed to have a good
estimation of cortisol levels. Lastly, this study is cross-
sectional and causality cannot be established, and conse-
quently these novel results in humans should be viewed as
hypothesis generating that motivates further investigation.Conclusions
This is the first study in humans investigating the associ-
ation between fatty acid type and HSD11B1expression in
adipose tissue. We show distinct relationships between
saturated and unsaturated FAs with regard to HSD11B1,
in accordance with previous findings in rats. Further research
is needed to establish causality, and determine whether
associations with FAs in VAT reflects dietary intake or
local endogenous FA metabolism, or both.
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